Los Angeles, CA – September 21, 2026 - Dr. Johnson V. John, Assistant Professor at the Terasaki Institute for Biomedical Innovation, has been awarded an NIH R01 grant to lead development of a next-generation, immunomodulatory wound dressing platform designed to accelerate healing in chronic wounds. Dr. John and his research team are tackling a persistent clinical challenge: chronic wounds that resist healing because they become locked in a prolonged inflammatory state.
Los Angeles, CA – September 1, 2026 - Another summer at the Terasaki Institute for Biomedical Innovation (TIBI) has come to a close, and with it, the 2026 Summer Internship Program. Kicking off on June 22 and continuing through mid-August, this year's cohort of 21 interns spent eight weeks of their summer immersed in biomedical research, entrepreneurial thinking, and scientific storytelling.
Wireless system continuously tracks pH, glucose, and lactate in perfusate and bile during donor liver preservation.
Los Angeles, CA – July 14, 2026 – More than 100,000 people in the United States are waiting for a lifesaving organ transplant. For patients in need of a liver transplant, determining whether a donor liver is healthy enough to transplant is a critical part of the process. Yangzhi Zhu, PhD, Principal Investigator and Assistant Professor at the Terasaki Institute for Biomedical Innovation, and collaborators at Mayo Clinic in Arizona have developed a real-time biosensing platform designed to help answer that question during donor liver preservation.
Los Angeles, CA – June 22, 2026 – Researchers at the Terasaki Institute for Biomedical Innovation have developed an injectable hydrogel, a water-based gel material, made from silk proteins and a plant-derived compound. In laboratory tests, the material promoted complete wound closure within 72 hours, suggesting a potential new approach to minimally invasive soft tissue repair.
Los Angeles, CA – June 15, 2026 – Researchers from the Terasaki Institute for Biomedical Innovation together with key pioneers in glioma biology, neuro-oncology, and stem cell biology, have published a comprehensive review in Society for Neuro-Oncology’s journal Neuro-Oncology outlining the evolving landscape of glioma organoid technologies and proposing a foundational classification framework to guide translational brain tumor research.
Los Angeles, CA – June 4, 2026 – Researchers at the Terasaki Institute for Biomedical Innovation and University of Arizona College of Medicine, have developed a topical gel formulation with 4-aminopyridine (4-AP) - to treat burn wounds, achieving near-complete closure in 21 days. The findings are published in the journal Biomaterials.
Los Angeles, CA — April 21, 2026 — The Terasaki Institute for Biomedical Innovation invites the public to its 2026 Open House on Saturday, April 25, from 10:00 AM to 2:00 PM. Free and open to all ages, the event offers a rare behind-the-scenes and witness firsthand how cutting-edge science is being translated into real-world healthcare solutions.
Los Angeles, CA — April 8, 2026 — The Terasaki Institute for Biomedical Innovation (TIBI) is proud to announce that Principal Investigator Dr. Yangzhi Zhu has published their research in Science Translational Medicine, marking a major milestone for the institute.